COBAS AMPLIPREP / COBAS TAQMAN ANALYZER

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2010-10-04 for COBAS AMPLIPREP / COBAS TAQMAN ANALYZER manufactured by Roche Diagnsotics, Ltd..

Event Text Entries

[1474503] A customer in (b)(6) filed a complaint stating that the cobas ampliprep / cobas taqman hcv test using amplilink software v 3. 2 generated a (b)(6) result of (b)(6) cp/ml due to an early ct value of the target caused by a tilted baseline of the target curve. It was unknown if this result affected any patient treatment.
Patient Sequence No: 1, Text Type: D, B5


[8758081] At the time this complaint was investigated, a review of the data showed the (b)(6) result was due to an early ct value of the target caused by a tilted baseline of the target curve. The elth algorithm caused this tilted curve. The issue is still under investigation. The issue is considered to be a rare occurence. The cap/ctm hcv test is intended to be used as a monitoring test in conjunction with the clinical presentation and other laboratory markers as an aid in assessing viral response to antiviral therapy as measured by changes in plasma nucleic acid levels. In that regard, to the extent that observed sudden titer shifts are inconsistent with previous test results and overall clinical presentation, they should not result in changes to established therapy regimes. We recognize that this medical device report is being filed beyond the 30-day reporting timeframe as outlined within 21 cfr 803. 50. During a review of our mdr process, we determined that not all events that occurred ex-us were being assessed for mdr reportability within the united states. As a result, all potentially critical complaints (us and ex-us) filed going back to 01-jan-2008 were reassessed to determine if any of those cases represented a mdr reportable event. During the retrospective review, this event was identified as being mdr reportable. We are taking appropriate internal corrective actions to prevent recurrence of late filings.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2010-00018
MDR Report Key1851234
Report Source05
Date Received2010-10-04
Date of Report2010-03-26
Date of Event2009-04-13
Date Mfgr Received2009-02-17
Date Added to Maude2012-01-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLIPREP / COBAS TAQMAN ANALYZER
Generic NameANALYZER, CHEMISTRY, MICRO, FOR CLINICAL USE
Product CodeJJF
Date Received2010-10-04
ID NumberAMPLILINK SOFTWARE V 3.2
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNSOTICS, LTD.
Manufacturer AddressFORRENSTRASSE ROTKREUZ, ZUG 6343 SZ 6343


Patients

Patient NumberTreatmentOutcomeDate
10 2010-10-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.